Beverley Peter Charles Leonard, Tchilian Elma Zaven
The University of Oxford, Nuffield Department of Clinical Medicine, Edward Jenner Institute for Vaccine Research, Compton, Berkshire, RG20 7NN, UK.
Expert Rev Vaccines. 2008 Oct;7(8):1165-72. doi: 10.1586/14760584.7.8.1165.
There is a worldwide epidemic of increasingly drug-resistant TB. Bacillus Calmette-Guérin vaccination provides partial protection against disseminated disease in infants but poor protection against later pulmonary TB. Cell-mediated protection against respiratory virus infections requires the presence of T cells in lung tissues, and the most effective prime-boost immunizations for Mycobacterium tuberculosis also induce lung-resident lymphocytes. These observations need to be taken into account when designing future vaccines against M. tuberculosis.
全球范围内耐药结核病呈日益流行之势。卡介苗接种可为婴儿预防播散性疾病提供部分保护,但对后期肺结核的保护作用较差。针对呼吸道病毒感染的细胞介导保护需要肺组织中存在T细胞,而针对结核分枝杆菌最有效的初免-加强免疫接种也会诱导肺驻留淋巴细胞。在设计未来的抗结核疫苗时需要考虑到这些观察结果。